Overview

Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Status:
Completed

Trial end date:
2016-11-08

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety and effectiveness of pracinostat when combined with azacitadine for patients who are 65 years of age or older and have Acute Myelogenous Leukemia (AML)

Phase:

Phase 2

Details

Lead Sponsor:

Helsinn Healthcare SA
MEI Pharma, Inc.

Treatments:

Azacitidine